Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey.
View / Open Files
Authors
Sardanelli, Francesco
Aase, Hildegunn S
Álvarez, Marina
Azavedo, Edward
Baarslag, Henk J
Balleyguier, Corinne
Baltzer, Pascal A
Beslagic, Vanesa
Bick, Ulrich
Bogdanovic-Stojanovic, Dragana
Briediene, Ruta
Brkljacic, Boris
Camps, Herrero Julia
Colin, Catherine
Cornford, Eleanor
Danes, Jan
de, Geer Gérard
Esen, Gul
Evans, Andrew
Fuchsjaeger, Michael H
Graf, Oswald
Hargaden, Gormlaith
Helbich, Thomas H
Heywang-Köbrunner, Sylvia H
Ivanov, Valentin
Jónsson, Ásbjörn
Kuhl, Christiane K
Lisencu, Eugenia C
Luczynska, Elzbieta
Mann, Ritse M
Marques, Jose C
Martincich, Laura
Mortier, Margarete
Müller-Schimpfle, Markus
Ormandi, Katalin
Panizza, Pietro
Pediconi, Federica
Pijnappel, Ruud M
Pinker, Katja
Rissanen, Tarja
Rotaru, Natalia
Saguatti, Gianni
Sella, Tamar
Slobodníková, Jana
Talk, Maret
Taourel, Patrice
Trimboli, Rubina M
Vejborg, Ilse
Vourtsis, Athina
Forrai, Gabor
Publication Date
2017-07Journal Title
European radiology
ISSN
0938-7994
Publisher
Springer
Volume
27
Pages
2737-2743
Language
English
Type
Article
This Version
VoR
Physical Medium
Print-Electronic
Metadata
Show full item recordCitation
Sardanelli, F., Aase, H. S., Álvarez, M., Azavedo, E., Baarslag, H. J., Balleyguier, C., Baltzer, P. A., et al. (2017). Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey.. European radiology, 27 2737-2743. https://doi.org/10.1007/s00330-016-4612-z
Abstract
EUSOBI and 30 national breast radiology bodies support mammography for population-based screening, demonstrated to reduce breast cancer (BC) mortality and treatment impact. According to the International Agency for Research on Cancer, the reduction in mortality is 40 % for women aged 50-69 years taking up the invitation while the probability of false-positive needle biopsy is <1 % per round and overdiagnosis is only 1-10 % for a 20-year screening. Mortality reduction was also observed for the age groups 40-49 years and 70-74 years, although with "limited evidence". Thus, we firstly recommend biennial screening mammography for average-risk women aged 50-69 years; extension up to 73 or 75 years, biennially, is a second priority, from 40-45 to 49 years, annually, a third priority. Screening with thermography or other optical tools as alternatives to mammography is discouraged. Preference should be given to population screening programmes on a territorial basis, with double reading. Adoption of digital mammography (not film-screen or phosphor-plate computer radiography) is a priority, which also improves sensitivity in dense breasts. Radiologists qualified as screening readers should be involved in programmes. Digital breast tomosynthesis is also set to become "routine mammography" in the screening setting in the next future. Dedicated pathways for high-risk women offering breast MRI according to national or international guidelines and recommendations are encouraged.
Sponsorship
Department of Health (via National Institute for Health Research (NIHR)) (NF-SI-0515-10067)
Identifiers
External DOI: https://doi.org/10.1007/s00330-016-4612-z
This record's URL: https://www.repository.cam.ac.uk/handle/1810/261300
Rights
Attribution 4.0 International, Attribution 4.0 International, Attribution 4.0 International, Attribution 4.0 International